Toxigenic enteric bacteria are an important cause of acute diarrhea; Vibrio cholerae and toxigenic Escherichia coli are the best-studied examples. E. coli may produce two enterotoxins, one heat-labile (LT) and one heat-stable. Cholera toxin and E. coli LT are effective antigens that readily induce neutralizing antibody. Previous studies by cross-neutralization with antisera have shown that cholera toxin and E. coli LT are antigenically similar but not identical (13) . It also appears that cholera toxin and E. coli LT are each homogenous antigenic products, even when produced by differing serotypes or biotypes of organisms (4, 5, 11) .
The potential role of antitoxic immunity in prophylaxis of diarrhea caused by toxigenic bacteria is an object of current investigation. Animals immunized with cholera toxin or toxoid are protected against intestinal challenge with cholera toxin (3, 6) or viable V. cholerae (6, 8) . Similarly, animals immunized with crude E. coli LT are protected against intestinal challenge with LT (10) . The possibility that immunization with one toxin/toxoid could protect against challenge with the other, while attractive, has received less attention. One study has shown that dogs repeatedly challenged with E. coli LT are protected against later challenge with cholera toxin, suggesting that cross-protection does exist (12) .
In this study we used a rat model to measure intestinal secretion induced by cholera toxin and E. coli LT and to show that prior immunization with cholera toxin/toxoid produces significant protection against challenge with either toxin.
MATERIALS AND METHODS Antitoxin-containing cells in gut mucosa. Cholera antitoxin-containing plasma cells were identified and enumerated in the lamina propria of frozen sections of distal ileum by a previously described fluorescent-antibody technique (7).
Statistics. Differences in mean secretory responses in groups of rats were analyzed by the t test. In immunized rats, the index of protection was calculated as the mean effective dose (ED50) of toxin in immunized rats divided by the ED5o of toxin in unimmunized rats.
RESULTS
In preliminary studies, it appeared that the proximal ileal segment secreted less fluid in response to challenge with cholera toxin than did the distal segment; challenge with 1.5 mg of crude cholera toxin gave 99 + 26 ,lI of fluid (proximal, n = 18) and 179 ± 36 al of fluid per cm (distal, n = 18) (mean ± standard error, P < 0.10). For immunized rats challenged with crude E. coli LT, response to 0.75 mg was significantly reduced (P < 0.001), but the response to 3 mg was not (P < 0.20).
The local and systemic immune responses to cholera toxin/toxoid are also summarized in Table 1 . Immunized rats had appreciable elevations in serum antitoxin titer and large numbers of antitoxin-containing cells in ileal lamina propria at the time of challenge.
DISCUSSION
The immunization technique used in this study, intraperitoneal priming followed by repeated intraintestinal boosting, although not suited for human use, was chosen because it is known to induce vigorous antitoxic responses in serum and in the lamina propria of the small bowel (7) . Challenge was performed when the mucosal immune response was near its peak (7). It is not possible, therefore, to say what role each of these responses played in the observed protection. Studies in dogs have shown that antitoxic protection can be derived either from serum antibody or from secretory antibody made by plasma cells in the lamina propria of the gut (9; N. F. Pierce and R. B. Sack, J. Infect. Dis., in press).
The threefold increase in ED5o for cholera toxin in immunized rats was similar to that previously observed in rabbits immunized parenterally with cholera toxin (6) . Much greater ED5o increases have been observed when rabbits immunized with toxin were challeged with graded doses of viable V. cholerae (6), probably because toxin was released slowly. Thus, the challenge techniques used in this study may appreciably underestimate the degree of protection that toxin/toxoid immunization might confer against natural infection. This study clearly shows that immunization with cholera toxin/toxoid protected against E. coli LT and that protection against E. coli LT and cholera toxin appeared equal. These results contrast with previous failures to show protection against E. coli LT in rabbits immunized parenterally with cholera toxin (13) or in dogs immunized intraintestinally with cholera toxin (12) , although protection against cholera toxin was shown in both studies. In the present study, the degree of cross-protection against E. coli LT also appeared greater than might be predicted by earlier studies, which showed that cholera antitoxin was only about 10 to 50% as effective in neutralizing E. coli LT as it was in neutralizing cholera toxin (13) . The reasons for these differences are not apparent.
Finally, this study suggests the important possibility that effective immunization with cholera toxin/toxoid might also protect against disease caused by LT-producing E. coli. The possibility exists that this protection might extend even further across species lines; Sandefur and Peterson have shown that immunization of rabbits with a form of purified cholera toxoid protects against intestinal challenge with Salmonella typhimurium, possibly by interfering with the action of a cholera-like toxin produced by this organism (personal communication 
